title: [Oral ketanserin in the treatment of pre-eclampsia].
abstract: Oral ketanserin was used in an attempt to control gestational proteinuric hypertension and to improve perinatal outcome in 20 patients before 34 weeks. The average duration of treatment was 9 days. These patients had advanced disease which progressed despite additional treatment with a diuretic and/or methyldopa.
authors.affiliation: Departement Verloskunde en Ginekologie, Tygerberg-hospitaal, KP.
authors.forename: V A
authors.initials: VA
authors.lastname: Hulme
authors.forename: H J
authors.initials: HJ
authors.lastname: Odendaal
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D007650:Ketanserin / Q000008:administration & dosage / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D013997:Time Factors
chemical_list: D007650:Ketanserin
vernacular_title: Orale ketanserien vir die behandeling van pre-eklampsie.